Mackay Shields LLC Enanta Pharmaceuticals Inc Transaction History

Mackay Shields LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $797,474 - $919,731	-19,375 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$43.36 - $53.53 $21,680 - $26,765	500 Added 2.65%	19,375 $887,000
Q2 2020 Jul 31, 2020	SELL	$46.37 - $57.58 $204,028 - $253,352	-4,400 Reduced 18.9%	18,875 $947,000
Q1 2020 May 08, 2020	BUY	$40.22 - $62.0 $213,166 - $328,600	5,300 Added 29.49%	23,275 $1.2 Million
Q4 2019 Feb 11, 2020	SELL	$57.95 - $66.61 $162,260 - $186,508	-2,800 Reduced 13.48%	17,975 $1.11 Million
Q3 2019 Nov 01, 2019	BUY	$60.08 - $88.17 $168,224 - $246,876	2,800 Added 15.58%	20,775 $1.25 Million
Q2 2019 Aug 13, 2019	BUY	$81.3 - $97.35 $909,177 - $1.09 Million	11,183 Added 164.65%	17,975 $1.52 Million
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $19,099 - $24,717	292 Added 4.49%	6,792 $481,000
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $555,490 - $821,405	6,500 New	6,500 $555,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $127M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.